Although studies have reported that 23.1% of acute CHB flare-ups are IgM positive [13], according to the current diagnostic criteria of hepatitis B in China, clinicians can classify cases according to the anti-HBc IgM test results. This evidence concerns the gene CD40LG and hepatitis B virus infection.